The fifth edition of the World Health Organization Classification of Tumors of the Central Nervous System (WHO2021) requires identifying IDH1 or IDH2 mutation without 1p19q co-deletion for diagnosing an astrocytoma [1]. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).